Fas ligand (cd95l) and cancer gene therapy

Gary J. Nabel

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{df8a59279c7f498f9e82a9a7afce019e,

title = "Fas ligand (cd95l) and cancer gene therapy",

author = "Nabel, {Gary J.}",

year = "1999",

doi = "10.1038/70149",

language = "English (US)",

volume = "17",

pages = "25",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "Nature Publishing Group",

number = "4s",

}

TY - JOUR

T1 - Fas ligand (cd95l) and cancer gene therapy

AU - Nabel, Gary J.

PY - 1999

Y1 - 1999

UR - http://www.scopus.com/inward/record.url?scp=84984774502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984774502&partnerID=8YFLogxK

U2 - 10.1038/70149

DO - 10.1038/70149

M3 - Comment/debate

AN - SCOPUS:84984774502

SN - 1087-0156

VL - 17

SP - 25

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 4s

ER -